Cargando…

Quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ?

The management of tissues and cellular samples by the pathologists in the infectious and tropical diseases pathology field in 2014 needs a strong knowledge of both morphological and molecular domains which includes the good control: (i) of the taxonomy of infectious and tropical diseases pathology l...

Descripción completa

Detalles Bibliográficos
Autor principal: Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131493/
https://www.ncbi.nlm.nih.gov/pubmed/24950861
http://dx.doi.org/10.1016/j.annpat.2014.04.006
_version_ 1783517251971842048
author Hofman, Paul
author_facet Hofman, Paul
author_sort Hofman, Paul
collection PubMed
description The management of tissues and cellular samples by the pathologists in the infectious and tropical diseases pathology field in 2014 needs a strong knowledge of both morphological and molecular domains which includes the good control: (i) of the taxonomy of infectious and tropical diseases pathology leading to the pathogens identification and (ii) of the ancillary methods which can be used in fixed samples in order to detect or better identify these pathogens. There is a recent paradox in France concerning the frequency of infectious diseases to be diagnosed in pathology laboratories and the progressive loss of pathologist's expertise in this domain. Different reasons could explain this statement including the omnipresence of the tumour lesions to be managed in a pathology laboratory as well as the recent constraints associated with the different biomarkers that are mandatory to be detected by immunohistochemistry and/or by molecular biology. Even if the microbiologists play a pivotal role for identifying the different pathogens as well as for the assessment of their sensitivity to the anti-microbial drugs, a large number of infectious diseases can be diagnosed only on fixed tissue and/or cells by the pathologists. The purpose of this review is to describe the current and future issues of infectious and tropical diseases diagnoses in pathology laboratories, in particular in France.
format Online
Article
Text
id pubmed-7131493
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71314932020-04-08 Quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ? Hofman, Paul Ann Pathol Article The management of tissues and cellular samples by the pathologists in the infectious and tropical diseases pathology field in 2014 needs a strong knowledge of both morphological and molecular domains which includes the good control: (i) of the taxonomy of infectious and tropical diseases pathology leading to the pathogens identification and (ii) of the ancillary methods which can be used in fixed samples in order to detect or better identify these pathogens. There is a recent paradox in France concerning the frequency of infectious diseases to be diagnosed in pathology laboratories and the progressive loss of pathologist's expertise in this domain. Different reasons could explain this statement including the omnipresence of the tumour lesions to be managed in a pathology laboratory as well as the recent constraints associated with the different biomarkers that are mandatory to be detected by immunohistochemistry and/or by molecular biology. Even if the microbiologists play a pivotal role for identifying the different pathogens as well as for the assessment of their sensitivity to the anti-microbial drugs, a large number of infectious diseases can be diagnosed only on fixed tissue and/or cells by the pathologists. The purpose of this review is to describe the current and future issues of infectious and tropical diseases diagnoses in pathology laboratories, in particular in France. Elsevier Masson SAS. 2014-06 2014-05-20 /pmc/articles/PMC7131493/ /pubmed/24950861 http://dx.doi.org/10.1016/j.annpat.2014.04.006 Text en Copyright © 2014 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Hofman, Paul
Quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ?
title Quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ?
title_full Quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ?
title_fullStr Quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ?
title_full_unstemmed Quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ?
title_short Quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en France ?
title_sort quelle place et quel avenir pour l’anatomo-cyto-pathologie des maladies infectieuses et tropicales en france ?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131493/
https://www.ncbi.nlm.nih.gov/pubmed/24950861
http://dx.doi.org/10.1016/j.annpat.2014.04.006
work_keys_str_mv AT hofmanpaul quelleplaceetquelavenirpourlanatomocytopathologiedesmaladiesinfectieusesettropicalesenfrance